380 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical http://www.zacks.com/stock/news/223442/zacks-industry-outlook-highlights-johnson-johnson-smith-nephew-medtronic-abbott-laboratories-and-st-jude-medical?cid=CS-ZC-FT-223442 Jul 14, 2016 - Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
MedTech Tailwinds at a Glance: Which Stocks to Buy? http://www.zacks.com/commentary/85844/medtech-tailwinds-at-a-glance-which-stocks-to-buy?cid=CS-ZC-FT-85844 Jul 13, 2016 - MedTech Tailwinds at a Glance: Which Stocks to Buy?
Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13 http://www.zacks.com/stock/news/223329/pfizer-pfe-gets-fda-nod-for-label-expansion-of-prevnar-13?cid=CS-ZC-FT-223329 Jul 13, 2016 - Pfizer Inc. (PFE) announced that the FDA has approved a label expansion of vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S. http://www.zacks.com/stock/news/223158/abbvies-abt-414-gets-rare-pediatric-disease-status-in-us?cid=CS-ZC-FT-223158 Jul 12, 2016 - AbbVie's (ABBV) ABT-414 has been granted Rare Pediatric Disease Designation in the U.S. for the treatment of pediatric patients with EGFR-amplified DIPG.
Abbott Laboratories (ABT) Miles D. White on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3966643-abbott-laboratories-abt-miles-d-white-q1-2016-results-earnings-call-transcript?source=feed_tag_transcripts Apr 20, 2016 - Abbott Laboratories (NYSE:ABT)Q1 2016 Earnings CallApril 20, 2016 9:00 am ETExecutivesScott Leinenweber - Vice President, Investor RelationsMiles D. White - Chairman & Chief Executive OfficerBrian B.
Abbott Laboratories (ABT) Q1 2016 Results - Earnings Call Webcast http://seekingalpha.com/article/3966057-abbott-laboratories-abt-q1-2016-results-earnings-call-webcast?source=feed_tag_transcripts Apr 20, 2016 - Earnings Conference Call Start time: April 20, 2016 at 09:00 AM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Edwards Completes CardiAQ Buyout, Resolves FORTIS Issue http://www.zacks.com/stock/news/188018/edwards-completes-cardiaq-buyout-resolves-fortis-issue?cid=CS-ZC-FT-188018 Aug 27, 2015 - Edwards Lifesciences Corp. (EW) recently completed the acquisition of California-based CardiAQ Valve Technologies, Inc.
Will Medtronic's Twelve Buy Expedite Growth in Mitral Valves? http://www.zacks.com/stock/news/187823/will-medtronics-twelve-buy-expedite-growth-in-mitral-valves?cid=CS-ZC-FT-187823 Aug 26, 2015 - Post-acquisition, Medtronic (MDT) believes Twelve's TMVR device will act as a significant growth opportunity for the company.
Abbott Laboratories (ABT) Plunges: Stock Falls by 7.3% http://www.zacks.com/stock/news/187526/abbott-laboratories-shares-fell-by-over-7-in-the-last-session?cid=CS-ZC-FT-187526 Aug 25, 2015 - Abbott Laboratories' shares fell by over 7% in the last session, continuing the recent downtrend for ABT, as the stock is now down over nearly 14% over the past one month
RobMarketsBlind's Latest Purchase http://www.zacks.com/stock/news/75653/robmarketsblinds-latest-purchase?cid=CS-ZC--75653 May 22, 2012 - RTMB's public record on this site's blog is a perfect 100%, all trades have been winners, no losers. RTMB has been posting these trades here for over a year now!

Pages: 1...333435363738

<<<Page 38